Tag: Breakthrough Therapy

May 23, 2019

Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate

Tonix Pharmaceuticals (NASDAQ:TNXP) has announced that it has in-licensed a Phase 2 asset, TNX-1300 for treating cocaine intoxication. As quoted...
April 24, 2019

La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118

La Jolla Pharmaceuticals (NASDAQ:LJPC) has announced the US Food and Drug Administration (FDA) has granted the company breakthrough therapy designation...
June 12, 2018

Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meetin

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced...